Principal Investigator: Dr Carina Dunlop, University of Surrey
425 results
Dr Alan Harper and NC3Rs-BHF PhD student Jacob Ranjbar have developed an artificial human blood vessel to study blood clotting in vitro and replace the use of mice in thrombosis research. They have successfully disseminated the model to the thrombosis community, including for new applications within cardiovascular research.
Dr Frank McCaughan and student, Dr Phil Barry, miniaturised a human cell-based model of early-stage lung cancer enabling the assay to replace some drug screening experiments using mice.
Principal Investigator: Dr Michael Colman, University of Leeds
Principal Investigator: Dr Gabriel Galea, University College London
Current contact: Dr Elliot Lilley
Professor Cathy Merry has developed synthetic hydrogels that support 3D culture for multiple cell types and used NC3Rs funding to support their application across multiple scientific disciplines.
Dr Paola Campagnolo has used NC3Rs funding from a Project grant and a Skills and Knowledge Transfer award to develop an ex vivo model of the epicardium to replace the use of mice for high throughput screening of cardiac therapies in academia and industry.
Principal Investigator: Professor Deborah Mason, Cardiff University
Principal Investigator: Professor Robert Hindges, King's College London
Principal Investigator: Dr Jonathan Ball, University of Exeter
Principal Investigator: Dr David Dickens, University of Liverpool
Principal Investigator: Professor Awen Gallimore, Cardiff University
Principal Investigator: Dr Laura Randle, University of Liverpool
Principal Investigator: Professor Manuel Mayr, Imperial College London
Principal Investigator: Professor Jennifer Rohn, University College London
Principal Investigator: Dr Lee Borthwick, Newcastle University
Principal Investigator: Dr Richard van Arkel, Imperial College London
Current contact: Dr Khia Dobbinson
Principal Investigator: Professor Andrew Peden, University of Sheffield
